P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT

• O. Albanyan,
• D. Kalos,
• J. Kim,
• R. Faramand,
• H. Elmariah,
• A. Mishra,
• T. Nishihori,
• L. Perez,
• M. Nieder,
• J. Pidala,
• N. Bejnayan

Affiliations

O. Albanyan

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

D. Kalos

2 Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, United States of America

J. Kim

2 Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, United States of America

R. Faramand

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

H. Elmariah

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

A. Mishra

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

T. Nishihori

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

L. Perez

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

M. Nieder

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

J. Pidala

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy

N. Bejnayan

1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy